The Case for RFID: A Pharmaceutical Manufacturer’s Perspective

By Doug

  • TAGS

Although the California State Board of Pharmacy has delayed implementing its e-pedigree requirement until 2015 and the U.S. Food and Drug Administration won’t release its pedigree plan for another year, drug manufacturer Cephalon is forging ahead with its own plans to implement RFID and an electronic drug pedigree solution for pharmaceutical products. Hear how and why the company is moving forward with its implementation plans. Speaker: Brian Brown...

BASIC

THIS RECORDING OR VIDEO IS AVAILABLE TO BASIC MEMBERS. PLEASE LOG IN TO VIEW IT. IF YOU ARE NOT CURRENTLY A SUBSCRIBER, PLEASE CLICK HERE TO SIGN UP.